카나프테라퓨틱스
9,810KRWMarket close of 10/27 (Tue)
Down -0.20%-20KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)10,030KRWUp +2.24%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 9,880
- High
- 10,380
- Low
- 9,670
- Day range
- Day range low 9,670 high 10,380, open 9,880, close 9,810, previous close 9,830
- Volume
- 8×10K shares
- 775.39 million KRW 0.54× the 20-session average
Market close of 10/27 (Tue)
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedOutside financial data coverage, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.20%usual range
- Trading value0.5×usual range
With 151 trading days, the 1-year position isn't calculated · First data date 3/16 (Mon)
See the full check report
바이오 R&D · stocks
View the whole 바이오 R&D sectorSame sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.